Find Dopamine Receptor Agonists, Dopamine Receptor Antagonists, Dopamine Receptor Inhibitor on Industry Directory, Reliable Manufacturer/Supplier/Factory from China.

Inquiry Basket (0)
Home > Products > Neuronal Signaling > Dopamine Receptor Inhibitor > Chlorpromazine HCl 69-09-0

Chlorpromazine HCl 69-09-0

Product Description

.cp_wz table {border-top: 1px solid #ccc;border-left:1px solid #ccc; } .cp_wz table td{border-right: 1px solid #ccc; border-bottom: 1px solid #ccc; padding: 5px 0px 0px 5px;} .cp_wz table th {border-right: 1px solid #ccc;border-bottom: 1px solid #ccc; padding: 5px 0px 0px 5px;}


Molecular Weight: 355.33 Chlorpromazine HCl is a dopamine and Potassium Channel Inhibitor with IC50 of 6.1 and 16 μM for inward-rectifying K+ currents and time-independent outward currents

Chlorpromazine affects miniature IPSCs (mIPSCs) by decreasing the
binding (kon) and by increasing the unbinding (koff) rates of GABAARs. Chlorpromazine modulates activated TRPA1 currents in a
voltage-dependent way, leading to a block at positive potentials and an
increased open probability at negative potentials.

Chlorpromazine independently down-regulates the production of various T
cell-derived lymphokines (IL-2, IFN-gamma, IL-4, TNF, and GM-CSF) and
up-regulates the secretion of IL-10 in an in vivo model of acute
superantigen-driven immune activation. Chlorpromazine -mediated
amplification of the SEB-driven Chlorpromazine secretion is accompanied
by an enhanced IL-10 mRNA accumulation. Chlorpromazine
protects mice, normal or adrenalectomized, and guinea pigs against
lethality of LPS, and inhibits TNF serum levels.


Chlorpromazine protects
against LPS lethality when administered 30 minutes (min) before,
simultaneously, or up to 10 min after LPS and is ineffective when given
30 min after LPS, paralleling the inhibitory effect on TNF production.
Chlorpromazine significantly inhibits LPS lethality and hepatotoxicity
in mice sensitized to LPS toxicity by actinomycin D, whereas under these
conditions DEX is inactive. Chlorpromazine protects
brain tissue from hypoxia-induced irreversible loss of synaptic
transmission in rats. Chlorpromazine also significantly delays the
occurrence of the hypoxia-induced spreading depression (SD) in rats.



Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)

Species Baboon Dog Monkey Rabbit Guinea pig Rat Hamster Mouse
Weight (kg) 12 10 3 1.8 0.4 0.15 0.08 0.02
Body Surface Area (m2) 0.6 0.5 0.24 0.15 0.05 0.025 0.02 0.007
Km factor 20 20 12 12 8 6 5 3

Animal A (mg/kg) = Animal B (mg/kg) multiplied by Animal B Km
Animal A Km



For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Rat dose (mg/kg) = mouse dose (22.4 mg/kg) × mouse Km(3) = 11.2 mg/kg
rat Km(6)







Chemical Information




Molecular Weight (MW) 355.33
Formula

C17H19ClN2S.HCl

CAS No. 69-09-0

Storage 3 years -20℃Powder
6 months-80℃in solvent (DMSO, water, etc.)
Synonyms Sonazine



Solubility (25°C) * In vitro DMSO 71 mg/mL (199.81 mM)
Water 71 mg/mL (199.81 mM)
Ethanol 71 mg/mL (199.81 mM)
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.




Chemical Name 2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine,hydrochloride (1:1)







Molarity Calculator
Dilution Calculator
Molecular Weight Calculator

Contact us if you need more details on 69-09-0. We are ready to answer your questions on packaging, logistics, certification or any other aspects about Chlorpromazine HCl、69-09-0 Chlorpromazine HCl. If these products fail to match your need, please contact us and we would like to provide relevant information.

Product Categories : Neuronal Signaling > Dopamine Receptor Inhibitor